305 related articles for article (PubMed ID: 19079987)
1. [Specific immune cell therapy against ovarian cancer in vivo and in vitro].
Chang XH; Cheng HY; Cheng YX; Ye X; Guo HF; Fu TY; Zhang L; Zhang G; Cui H
Ai Zheng; 2008 Dec; 27(12):1244-50. PubMed ID: 19079987
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.
Yang W; Feng J; Chang X; Fu T; Ye X; Zhang H; Li X; Wen H; Feng L; Tong C; Cui H
Gynecol Oncol; 2007 Apr; 105(1):238-43. PubMed ID: 17383546
[TBL] [Abstract][Full Text] [Related]
3. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
[TBL] [Abstract][Full Text] [Related]
4. [Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells].
Yang WL; Cui H; Feng J; Chang XH; Fu TY; Ye X; Zhang H; Li XP; Wen HW; Feng LM; Tong CR
Ai Zheng; 2004 Dec; 23(12):1639-45. PubMed ID: 15601552
[TBL] [Abstract][Full Text] [Related]
5. Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.
Cheng H; Ma R; Wang S; Wang Y; Li Y; Tang Z; Dou S; Wang Y; Zhu H; Ye X; Zhang T; Zhang Y; Li S; Zhao Y; Li Y; Cui H; Chang X
Front Immunol; 2021; 12():707468. PubMed ID: 34408750
[TBL] [Abstract][Full Text] [Related]
6. [In vitro study of the antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY; Ye X; Zhu HL; Cheng HY; Cheng YX; Guo HF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):480-4. PubMed ID: 16224517
[TBL] [Abstract][Full Text] [Related]
7. A CTLA-4 blocking strategy based on Nanoboby in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects.
Wang W; Wang X; Yang W; Zhong K; He N; Li X; Pang Y; Lu Z; Liu A; Lu X
BMC Cancer; 2021 Sep; 21(1):1029. PubMed ID: 34525966
[TBL] [Abstract][Full Text] [Related]
8. [The induction of specific immunity to human ovarian carcinoma cells by anti-idiotypic antibodies].
Lu WY; Qian HN; Li WJ
Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):27-9, 60-1. PubMed ID: 8033621
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].
Yang XJ; Huang JA; Lei W; Zhu YB; Zhang XG
Ai Zheng; 2006 Nov; 25(11):1329-33. PubMed ID: 17094896
[TBL] [Abstract][Full Text] [Related]
10. [Study of immunization protocol of ovarian carcinoma associated 6B11 anti-idiotypical minibody].
Zhu HL; Li Y; Chang XH; Cui H; Feng J; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):52-6. PubMed ID: 16635330
[TBL] [Abstract][Full Text] [Related]
11. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
[TBL] [Abstract][Full Text] [Related]
12. [Anti-tumor effect of cytotoxic T lymphocytes induced by soluble antigen of ovarian carcinoma and anti-CD3 monoclonal antibody on ovarian carcinoma].
Zhang Q; Wan Y; Zhai H
Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):355-7. PubMed ID: 10806675
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with monoclonal anti-idiotypic antibody on immunocompetent mice bearing human ovarian carcinoma.
Qian H; Wang J; Feng J
Chin Med J (Engl); 1997 Apr; 110(4):259-63. PubMed ID: 9594224
[TBL] [Abstract][Full Text] [Related]
14. Construction, expression, and function of 6B11ScFv-mIL-12, a fusion protein that attacks human ovarian carcinoma.
Cheng H; Ye X; Chang X; Ma R; Cong X; Niu Y; Zhang M; Liu K; Cui H; Sang J
Med Oncol; 2015 Apr; 32(4):130. PubMed ID: 25794492
[TBL] [Abstract][Full Text] [Related]
15. Killing effects of Huaier Granule combined with DC-CIK on nude mice transplanted with colon carcinoma cell line.
Sun WW; Dou JX; Zhang L; Qiao LK; Shen N; Zhao Q; Gao WY
Oncotarget; 2017 Jul; 8(28):46081-46089. PubMed ID: 28537906
[TBL] [Abstract][Full Text] [Related]
16. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.
Chan JK; Hamilton CA; Cheung MK; Karimi M; Baker J; Gall JM; Schulz S; Thorne SH; Teng NN; Contag CH; Lum LG; Negrin RS
Clin Cancer Res; 2006 Mar; 12(6):1859-67. PubMed ID: 16551871
[TBL] [Abstract][Full Text] [Related]
17. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y
Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809
[TBL] [Abstract][Full Text] [Related]
18. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
[TBL] [Abstract][Full Text] [Related]
19. Anti-idiotypic monoclonal antibodies against anti-ovarian carcinoma monoclonal antibody COC166-9. Generation and application.
Qian HN; Lu WY
Chin Med J (Engl); 1994 Feb; 107(2):99-103. PubMed ID: 8194388
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and characterization of monoclonal anti-anti-idiotypic antibody (3D12) of epithelial ovarian carcinoma].
Zhang C; Cui H; Li Xp; Ye X; Fu Ty; Feng J; Chang Xh; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):170-3. PubMed ID: 18458693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
